Abstract
With the rapid development of high-throughput techniques, mass spectrometry has been widely used for large-scale protein analysis. To search for the existing proteins, discover biomarkers, and diagnose and prognose diseases, machine learning methods are applied in mass spectrometry data analysis. This paper reviews the applications of five kinds of machine learning methods to mass spectrometry data analysis from an algorithmic point of view, including support vector machine, decision tree, random forest, naive Bayesian classifier and deep learning.
Keywords: Mass spectrometry, high-throughput technique, machine learning, deep learning, computational proteomics, protein identification.
Graphical Abstract
Current Proteomics
Title:Machine Learning for Mass Spectrometry Data Analysis in Proteomics
Volume: 18 Issue: 5
Author(s): Juntao Li, Kanglei Zhou* Bingyu Mu*
Affiliation:
- School of Computer Science and Engineering, Beihang University, Beijing,China
- College of Arts and Design, Zhengzhou University of Light Industry, Zhengzhou,China
Keywords: Mass spectrometry, high-throughput technique, machine learning, deep learning, computational proteomics, protein identification.
Abstract: With the rapid development of high-throughput techniques, mass spectrometry has been widely used for large-scale protein analysis. To search for the existing proteins, discover biomarkers, and diagnose and prognose diseases, machine learning methods are applied in mass spectrometry data analysis. This paper reviews the applications of five kinds of machine learning methods to mass spectrometry data analysis from an algorithmic point of view, including support vector machine, decision tree, random forest, naive Bayesian classifier and deep learning.
Export Options
About this article
Cite this article as:
Li Juntao , Zhou Kanglei*, Mu Bingyu *, Machine Learning for Mass Spectrometry Data Analysis in Proteomics, Current Proteomics 2021; 18 (5) . https://dx.doi.org/10.2174/1570164617999201023145304
DOI https://dx.doi.org/10.2174/1570164617999201023145304 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Isolation, Characterization and Preliminary Cytotoxic and Antifungal Evaluations of Novel Lancifoliate Isolated from Methanol Extract of <i>Conocarpus lancifolius</i>
Anti-Cancer Agents in Medicinal Chemistry Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets The Anti-Inflammatory Role of Annexin-1 in Arthritis
Current Rheumatology Reviews T Cell Receptor Bias in Humans
Current Immunology Reviews (Discontinued) Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets Computational Studies in Drug Design Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors
Current Cancer Drug Targets Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection
Current Drug Targets Apoptosis-Induction is A Novel Therapeutic Strategy for Gastrointestinal and Liver Cancers
Current Gene Therapy Perspectives of Benzimidazole Derivatives as Anticancer Agents in the New Era
Anti-Cancer Agents in Medicinal Chemistry Anti-Angiogenesis in the Treatment of Genito-Urinary Cancers: Last Updates
Current Angiogenesis (Discontinued) Vitamin, Mineral, and Drug Absorption Following Bariatric Surgery
Current Drug Metabolism The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors
Current Drug Metabolism Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology Personalized and Predictive Medicine in Turkey: A Symposium Report of the Istanbul Working Group on Personalized Medicine, Istanbul, Turkey, September 10-12, 2009
Current Pharmacogenomics and Personalized Medicine Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis
Anti-Cancer Agents in Medicinal Chemistry Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy
Clinical Cancer Drugs